[Radical Thoracoscopic Esophagectomy for Elderly Patients with Advanced Esophageal Cancer]

Gan To Kagaku Ryoho. 2017 Nov;44(12):1784-1786.
[Article in Japanese]

Abstract

We report a case of an elderly patient with advanced esophageal cancer who underwent multidisciplinary treatment. An 86-year-old male consulted our hospital with complaints of pharynx discomfort and difficulty in swallowing. He was preoperatively diagnosed with esophageal cancer, T3N2M0, Stage III . We performed 2 courses of cisplatin plus 5-FU therapy as neoadjuvant chemotherapy. The primary tumor and metastatic lymph nodes reduced in size, and thoracoscopic esophagectomy in the prone position was performed. Pathological findings were esophageal cancer, pT3-Ad, INF b, ly2, v1, IM0, pPM0, pDM0, pRM1, pN3, pStage III . As the radical margin was positive, chemoradiotherapy was performed. We continued postoperative chemotherapy for approximately 1 year, and the patient has survived without relapse for 4 years from esophagectomy. Even in patients over 80 years old, long-term prognosis can be expected by performing radical surgery and chemoradiotherapy.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Drug Combinations
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / therapy*
  • Esophagectomy*
  • Humans
  • Male
  • Oxonic Acid / administration & dosage
  • Silicates / therapeutic use
  • Tegafur / administration & dosage
  • Thoracoscopy*
  • Titanium / therapeutic use

Substances

  • Drug Combinations
  • Silicates
  • titanium silicide
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid
  • Titanium
  • Cisplatin